Nanomaterials are defined as a natural, incidental or manufactured materials consisting of solid particles that are present, either on their own or as identifiable constituent particles in aggregates or agglomerates, and where 50 % or more of these particles in the number-based size distribution fulfil at least one of the following conditions[1],[2]: one or more […]
In the rapidly evolving landscape of healthcare, precision medicine has emerged as a groundbreaking approach to tailor medical treatment to the individual characteristics of each patient. At the forefront of this revolution are companion diagnostics (CDx), an integral component of medical devices that holds the key to unlocking personalized and targeted therapies. Let’s explore the […]
Workers’ safety is a fundamental concern in any industry. Employees in pharmaceutical and chemical manufacturing sectors may be exposed to drug substances or chemicals that pose potential health risks in the workplace. Therefore, to protect employees from potential health hazards in the workplace, it is crucial to establish and adhere to safety limits, among this […]
In the realm of cosmetics, it is imperative that product labels encompass a comprehensive array of mandatory information, ensuring transparency and consumer awareness. Serving as a crucial link of communication, these labels elucidate essential details about the cosmetic product to the end user. Beyond mere formality, adhering to these label requirements reflects a commitment to […]
Back in November 9, 2023 the European Court of Justice, after a long legal battle against Global Silicones and others (the list is long: Dow Silicones UK Ltd, Evonik Operations GmbH, Shin-Etsu Silicones Europe BV, just to name a few) confirmed the classification of D4, D5 and D6 as substances of very high concern (SVHC), […]
The Regulation (EU) 2017/745 on medical devices is designed to establish a robust regulatory framework, ensuring a high standard of quality and safety for products. This comprehensive regulation addresses crucial aspects such as biocompatibility and the chemical and physical characterization of materials. These pivotal elements are also outlined in Annex I of the Regulation, focusing […]
A new article was released in Molecular Pain magazine, in which our estimated colleague Giorgina Mangano is one of the authors! Benzydamine, an active pharmaceutical compound, was shown to have analgesic and anaesthetic properties after local applications. The chemical is generally used in oral care pharmaceutical preparations due to its anti-inflammatory actions, acting on pro-inflammatory […]
In our earlier discussion, we delved into the intricacies of the classic Permitted Daily Exposure (PDE) and its functioning (click here for an in-depth exploration!). However, the application of PDE extends beyond human pharmaceuticals, finding relevance also in veterinary drugs, particularly those manufactured in shared facilities. As a quick recap, the PDE servs to determine […]
According to the European regulation for cosmetics (EU Reg. n° 1223/2009) the responsible person who places cosmetic products on the European market must be able to demonstrate that such products are safe for human health, under normal conditions of use or reasonably foreseeable, in order to always guarantee maximum consumer protection. In order for the […]
ECHA has recently released a comprehensive IUCLID dataset comprising 528 approved pharmaceuticals, showcasing information gathered from both animal studies and human data. This addition to the dataset marks a significant step forward in supporting the development of alternatives to traditional animal testing. This update involves the inclusion of data on 180 new substances, complementing the […]










